Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. [electronic resource]
Producer: 20180830Description: 233-242 p. digitalISSN:- 1880-4233
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- Antibiotics, Antineoplastic -- pharmacology
- Apoptosis -- drug effects
- Biomarkers, Tumor -- genetics
- Breast Neoplasms -- drug therapy
- Cyclooctanes -- pharmacology
- Doxorubicin -- pharmacology
- Drug Resistance, Multiple -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lignans -- pharmacology
- Phosphorylation
- Polycyclic Compounds -- pharmacology
- STAT3 Transcription Factor -- genetics
- Signal Transduction -- drug effects
- Transcription Factor RelA -- genetics
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.